Cite
HARVARD Citation
Martín, M. et al. (n.d.). Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer. Current medical research and opinion. pp. 1129-1137. [Online].